A new study published in the journal of Eye showed that in some ethnic groups like the non-Hispanic Whites and ...

Advanced mechanical design to address both subacute, organized thrombus and more dense, fibrotic tissue; devices with a low ...

A discussion on pathophysiology, patient workup, gaps in data and disease-specific tools, and postprocedural follow-up and ...

To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ...

Roche has axed one of the obesity assets from its $2.7 billion Carmot Therapeutics buyout, sending the molecule to the scrap heap months after hyping its potential to drive weight loss past the GLP-1 ...

The commercial license will become effective upon completion of the transition of commercial rights from Biogen back to ...

Global regulatory advancements in biosimilars enhance access to affordable treatments for autoimmune disorders, bone diseases ...

DAEJEON, South Korea I July 28, 2025 I Alteogen Inc. (KOSDAQ:196170) announced today that the European Medicines Agency's (EMA) Committee for Medicinal ...

Real-world data confirm Mvasi's safety as a cost-effective alternative to reference bevacizumab (Avastin) for treating ...

Researchers reveal that microglia, the brain's immune cells, play a key role in protecting retinal health and managing eye ...

I had a complete hysterectomy in my late 40s due to endometriosis. I am now 68 and have been on 0.1-mg patches of estradiol ...